[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/main/docs/Risk/index.md) >> Individual ID:PBN__Risk_1913 

# __Disease severity in re-infected patients__

## Property: has_RiskType

* [medical](https://github.com/mm80843/T3.5/blob/main/docs/RiskType/PBN__RiskType_15.md)

## People affected by this risk

* [researchers](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_2.md)
* [re-infected patients](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_1295.md)

## Name of the risk

Difficulty in assessing the impact of re-infections on disease severity.

## Property: has_RiskISO_Purpose

* [Health and care](https://github.com/mm80843/T3.5/blob/main/docs/RiskISO/PBN__RiskISO_Impact_3.md)

## Closest similar item

* [Variability in disease severity in reinfected patients](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_863.md)
* [Variation in protection against re-infections](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1914.md)
* [Infection and disease](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2618.md)
* [Low testing frequency in previously infected individuals](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_864.md)
* [Unreported infections](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3174.md)
* [Changes in disease distribution](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1848.md)
* [High infection-to-fatality ratio, particularly for vulnerable populations](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2111.md)
* [Higher risk of reinfection in unvaccinated individuals](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_862.md)
* [Delay in diagnosis and poor infection control practices](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2383.md)
* [Higher COVID-19 infection rate](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2681.md)

## Description of the risk

Unclear difference in disease severity between re-infected patients and patients with initial infection.

## Technologies linked to the risk

* [comparative studies and data analysis technologies](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_1311.md)

## Property: has_RiskHealth

* [physical](https://github.com/mm80843/T3.5/blob/main/docs/RiskHealth/PBN__RiskHealth_0.md)

## Mitigations of this risk

* [Conduct comparative studies on disease severity between re-infected and initially infected patients.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2515.md)

## Articles mentionning the risk

* [Contributions to the mitigation of the COVID-19 pandemic](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_245.md)

## Property: has_RiskISO_Impact

* [Health and care](https://github.com/mm80843/T3.5/blob/main/docs/RiskISO/PBN__RiskISO_Purpose_0.md)

## Property: has_RiskGBN

* [Yes](https://github.com/mm80843/T3.5/blob/main/docs/RiskGBN/PBN__RiskGBN_1.md)

## Stakeholders who can mitigate this risk

* [researchers](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_2.md)
* [healthcare providers](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_121.md)

